RSV fusion (F) protein DNA vaccine provides partial protection against viral infection
about
Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine designNew insights for development of a safe and protective RSV vaccineChitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticlesRobust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gag.Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine.IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles.Immunogenicity of RSV F DNA Vaccine in BALB/c Mice.Targeting RSV with vaccines and small molecule drugs.Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.Respiratory syncytial virus vaccine development
P2860
Q27021304-7509ECAE-781E-493C-8A16-F019466CEBCEQ34249859-E1AC963F-BBB1-4EDA-94A5-55DF1D1F1819Q34391647-CA768E7E-AF6A-4272-B2F1-90863B670155Q35080032-76C691E1-DD68-44E0-A643-E7828957725AQ35159523-FE11B74D-EDE9-4C14-8B7B-BD1A8C4B23A2Q35491580-5DAFE1CD-4D48-4960-B5B6-2F56AB329B7AQ36893661-50CA534D-7B93-4BE0-BB97-FB32399C64E0Q37263840-09620766-C7EC-4B1D-88CB-80E10F24E348Q37328584-EC232253-D27B-4E21-A8FC-D29DAA00C76EQ37412509-7269A011-9337-4D64-8D9F-B067673B0E65Q37473416-00976D32-08CD-4635-BE3C-674F7C6A0413Q38921013-85E2FB76-8B29-48AB-AB88-AFB2174525C4Q56893551-C8451F8B-AF31-44A6-B62E-7178DAA17FAB
P2860
RSV fusion (F) protein DNA vaccine provides partial protection against viral infection
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
RSV fusion (F) protein DNA vaccine provides partial protection against viral infection
@ast
RSV fusion (F) protein DNA vaccine provides partial protection against viral infection
@en
type
label
RSV fusion (F) protein DNA vaccine provides partial protection against viral infection
@ast
RSV fusion (F) protein DNA vaccine provides partial protection against viral infection
@en
prefLabel
RSV fusion (F) protein DNA vaccine provides partial protection against viral infection
@ast
RSV fusion (F) protein DNA vaccine provides partial protection against viral infection
@en
P2093
P2860
P1433
P1476
RSV fusion (F) protein DNA vaccine provides partial protection against viral infection
@en
P2093
Hongzhuan Wu
Shreekumar R Pillai
Vida A Dennis
P2860
P356
10.1016/J.VIRUSRES.2009.06.012
P577
2009-06-21T00:00:00Z